BioSpace News Archive

Biotech Bay

Presidio Health Announces General Availability of Hospitalist Revenue Cycle Functionality

Today, Presidio Health, a healthcare technology and clinical intelligence company, announced the general availability of hospitalist coding and business intelligence functionality in their PerformMD™ and PerformCycle™ solutions.

August 13, 2019

·

2 min read

Job Trends

KromaTiD Announces Closing of A Round Financing

KromaTiD, Inc. announced today that it has successfully completed its A round of financing with Denver-based firm First Capital Ventures.

August 13, 2019

·

1 min read

Business

American Logistics and Uber Health Announce Partnership to Drive Transportation Innovation in the Healthcare Industry

Today, American Logistics Company (ALC) announced a partnership with Uber Health, which is the rideshare company’s first national collaboration with a healthcare transportation management company.

August 13, 2019

·

4 min read

Deals

Portola Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Portola Pharmaceuticals, Inc. announced the pricing of its underwritten public offering of 8,035,715 shares of its common stock at a price to the public of $28.00 per share.

August 13, 2019

·

3 min read

Screening Libraries Diversified at BOC Sciences for Medicinal Chemistry Research

To meet the newly arising needs in the field of drug discovery, BOC Sciences announced to further diversify its screening libraries for researchers engaged with medicinal chemistry research on August 13, 2019.

August 13, 2019

·

2 min read

Policy

CTD Holdings Announces Filing of Data From Expanded Access Program in Late Onset Alzheimer’s Disease in Support of Its Patent Application Filed In 2018

CTD Holdings, Inc. announced that it has filed supporting data for its patent application titled “Methods for Treating Alzheimer’s Disease.” The original patent application was filed October 29, 2018 for the use of hydroxypropyl beta cyclodextrins in the treatment of Alzheimer’s Disease.

August 13, 2019

·

3 min read

Drug Development

Harvest One Phase II Clinical Trials on Satipharm CBD GelPell Published in Peer-Reviewed Medical Journal

Harvest One Inc. (“Harvest One” or the “Company”) (TSXV: HVT; OTCQX: HRVOF), through its wholly-owned subsidiary Satipharm Ltd. (“Satipharm”), today announced positive results of a Phase 2 clinical trial of its CBD GelPell® capsules in the management of Treatment Resistant Epilepsy

August 13, 2019

·

6 min read

Pharm Country

Intraprise Health Launches Software Service to Battle Security Breaches in Healthcare Organizations

Utilizing more than a decade of expertise in security and technology for healthcare clients, Intraprise Health has created BluePrint Protect™ Security Risk Management Software

August 13, 2019

·

3 min read

Business

KIYATEC Announces Addition of Capital Health as Clinical Site in Trial to Predict GBM Patient-Specific Response to Cancer Drugs Prior to Treatment

KIYATEC, Inc. today announced that Capital Health has joined its U.S. clinical trial, 3D-PREDICT, to validate the company’s test as a patient-specific predictor of response to cancer therapies in glioblastoma (GBM) and anaplastic astrocytoma (AA) patients.

August 13, 2019

·

3 min read

Genetown

Debbie’s Dream Foundation to Host FREE Stomach Cancer Education Symposium and Live Webcast at Dana-Farber Cancer Institute

Patients, families, and caregivers are invited to learn about gastric cancer and other cancer-related issues from oncology experts

August 13, 2019

·

3 min read